Literature DB >> 18293186

Serum alpha-1-antitriypsin levels in patients with pseudoexfolative syndrome.

Tongabay Cumurcu1, Huseyin Ozyurt, Helin Deniz Demir, Huseyin Yardim.   

Abstract

PURPOSE: To evaluate the levels of serum alpha 1-antitrypsin in patients with pseudoexfoliation syndrome (PEX) and healthy control subjects without PEX.
MATERIAL AND METHODS: Forty-four patient with PEX and 40 healthy control subjects (84 subjects total) were enrolled into the study. Serum ATT levels were measured using nephelometry.
RESULTS: The mean serum AAT concentration in PEX group was significantly higher than in the controls (p=0.0001).
CONCLUSION: Serum AAT levels were found to be increased in patients with PEX. Increased serum AAT levels in PEX may explain the role of inflammation in this group of patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18293186     DOI: 10.1080/02713680701861752

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  5 in total

1.  Serum YKL-40 levels as a novel marker of inflammation and endothelial dysfunction in patients with pseudoexfoliation syndrome.

Authors:  K Türkyılmaz; V Öner; A Kırbas; M S Sevim; B Sekeryapan; G Özgür; M Durmus
Journal:  Eye (Lond)       Date:  2013-05-10       Impact factor: 3.775

2.  Elevated neutrophil-to-lymphocyte ratio in pseudoexfoliation syndrome.

Authors:  B E Kurtul; P A Ozer; E U Kabatas
Journal:  Eye (Lond)       Date:  2016-05-06       Impact factor: 3.775

Review 3.  Pseudoexfoliation syndrome and cardiovascular diseases.

Authors:  Georgios K Andrikopoulos; Dimitrios K Alexopoulos; Sotirios P Gartaganis
Journal:  World J Cardiol       Date:  2014-08-26

4.  Early-onset Pseudoexfoliation Syndrome following Multiple Intraocular Procedures.

Authors:  Heydar Amini; Ramin Daneshvar; Yadollah Eslami; Sasan Moghimi; Nima Amini
Journal:  J Ophthalmic Vis Res       Date:  2012-07

5.  Elevated levels of plasma tumor necrosis factor alpha in patients with pseudoexfoliation glaucoma.

Authors:  Altaf A Kondkar; Taif A Azad; Faisal A Almobarak; Hatem Kalantan; Saleh A Al-Obeidan; Khaled K Abu-Amero
Journal:  Clin Ophthalmol       Date:  2018-01-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.